1. Home
  2. HROW vs DV Comparison

HROW vs DV Comparison

Compare HROW & DV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harrow Inc.

HROW

Harrow Inc.

HOLD

Current Price

$40.64

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo DoubleVerify Holdings Inc.

DV

DoubleVerify Holdings Inc.

HOLD

Current Price

$10.77

Market Cap

1.9B

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
HROW
DV
Founded
1998
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Computer Software: Prepackaged Software
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.9B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
HROW
DV
Price
$40.64
$10.77
Analyst Decision
Strong Buy
Buy
Analyst Count
8
17
Target Price
$68.86
$16.59
AVG Volume (30 Days)
579.2K
2.1M
Earning Date
03-16-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
0.26
Revenue
$250,042,000.00
$733,324,000.00
Revenue This Year
$38.57
$17.87
Revenue Next Year
$42.17
$10.36
P/E Ratio
N/A
$41.14
Revenue Growth
47.83
14.86
52 Week Low
$20.85
$7.64
52 Week High
$54.85
$23.11

Technical Indicators

Market Signals
Indicator
HROW
DV
Relative Strength Index (RSI) 31.23 45.77
Support Level $44.55 $10.62
Resistance Level $44.05 $11.23
Average True Range (ATR) 2.08 0.32
MACD -0.96 0.02
Stochastic Oscillator 1.26 51.03

Price Performance

Historical Comparison
HROW
DV

About HROW Harrow Inc.

Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.

About DV DoubleVerify Holdings Inc.

DoubleVerify Holdings Inc is a digital media measurement and analytics software platform. Its solutions provide advertisers with unbiased data analytics that enable them to increase the effectiveness, quality, and return on their digital advertising investments. Its DV Authentic Ad, a proprietary metric of digital media quality, measures whether a digital ad was delivered in a brand-suitable environment, fully viewable, by a real person, and in the intended geography. The company's software interface, DV Pinnacle, delivers these metrics to customers in real time, allowing them to access critical performance data on their digital transactions. Geographically, the company operates in the United States and also has a presence in Germany, Singapore, France, Canada, Japan, and other countries.

Share on Social Networks: